BACH1 and breast carcinoma: While RKIP belongs to the ‘team’ promoting an epithelial and tamoxifen-sensitive cell state in breast cancer, BACH1 is a part of the ‘team’ enabling a mesenchymal and tamoxifen-resistant phenotype.